ZVSA

ZyVersa Therapeutics

Delisted

ZVSA was delisted on the 16th of July, 2025.

8 hedge funds and large institutions have $86.2K invested in ZyVersa Therapeutics in 2024 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, reducing their positions, and 2 closing their positions.

Holders
8
Holders Change
+2
Holders Change %
+33.33%
% of All Funds
0.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
3
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Citigroup
1
Citigroup
New York
$37.1K +$37.1K +35,035 New
VF
2
Virtu Financial
New York
$27K +$27K +25,259 New
Renaissance Technologies
3
Renaissance Technologies
New York
$13.7K +$13.7K +12,961 New
UBS Group
4
UBS Group
Switzerland
$4.44K +$3.98K +3,754 +867%
TRCT
5
Tower Research Capital (TRC)
New York
$3.69K +$972 +917 +36%
Bank of America
6
Bank of America
North Carolina
$115 +$107 +101 +1,263%
SS
7
SBI Securities
Japan
$53 +$53 +50 New
Morgan Stanley
8
Morgan Stanley
New York
$1
JPMorgan Chase & Co
9
JPMorgan Chase & Co
New York
-$2 -1 Closed